胃底静脉曲张的球囊闭塞逆行经静脉闭塞与聚桂醇硬化泡沫

Q3 Medicine Journal of Interventional Medicine Pub Date : 2022-08-01 DOI:10.1016/j.jimed.2022.06.002

Zhiyang Wu , Wei Wu , Cheng Tao , Qin Liu , Wenchang Li , Qinbing Wang , Wei Huang , Junwei Gu , Xiaoyan Fei , Zhongmin Wang , Xiaoyi Ding

{"title":"胃底静脉曲张的球囊闭塞逆行经静脉闭塞与聚桂醇硬化泡沫","authors":"Zhiyang Wu , Wei Wu , Cheng Tao , Qin Liu , Wenchang Li , Qinbing Wang , Wei Huang , Junwei Gu , Xiaoyan Fei , Zhongmin Wang , Xiaoyi Ding","doi":"10.1016/j.jimed.2022.06.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>To evaluate the safety and efficacy of balloon-occluded retrograde transvenous obliteration (BRTO) using lauromacrogol sclerosant foam for gastric varices (GVs) with gastrorenal venous shunts.</p></div><div><h3>Methods</h3><p>Data of GV patients treated with BRTO using lauromacrogol sclerosant foam in 2016–2020 were retrospectively analyzed along with procedural success rate, complications, and follow-up efficacy.</p></div><div><h3>Results</h3><p>A total of 31 patients were treated with BRTO. The sclerosant foam was prepared by mixing iodinated oil, lauromacrogol, and air at a 1:2:3 ratio. The BRTO procedure was successfully completed in 93.5% of patients. One patient was allergic to the lauromacrogol injection. A mild postoperative fever occurred in three patients. One patient experienced grand mal seizures after the procedure. There was no significant difference in the median Child-Turcotte-Pugh scores before versus after BRTO. Complete GV resolution was observed in 93.1% of patients. One patient underwent endoscopic treatment for the development of high-risk esophageal varices. Another patient underwent transjugular intrahepatic portosystemic shunt placement for the aggravation of ascites.</p></div><div><h3>Conclusions</h3><p>Lauromacrogol sclerosant foam is safe and effective in patients undergoing BRTO for GV.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":"5 3","pages":"Pages 138-142"},"PeriodicalIF":0.0000,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cf/76/main.PMC9617148.pdf","citationCount":"1","resultStr":"{\"title\":\"Balloon-occluded retrograde transvenous obliteration with lauromacrogol sclerosant foam for gastric varices\",\"authors\":\"Zhiyang Wu , Wei Wu , Cheng Tao , Qin Liu , Wenchang Li , Qinbing Wang , Wei Huang , Junwei Gu , Xiaoyan Fei , Zhongmin Wang , Xiaoyi Ding\",\"doi\":\"10.1016/j.jimed.2022.06.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><p>To evaluate the safety and efficacy of balloon-occluded retrograde transvenous obliteration (BRTO) using lauromacrogol sclerosant foam for gastric varices (GVs) with gastrorenal venous shunts.</p></div><div><h3>Methods</h3><p>Data of GV patients treated with BRTO using lauromacrogol sclerosant foam in 2016–2020 were retrospectively analyzed along with procedural success rate, complications, and follow-up efficacy.</p></div><div><h3>Results</h3><p>A total of 31 patients were treated with BRTO. The sclerosant foam was prepared by mixing iodinated oil, lauromacrogol, and air at a 1:2:3 ratio. The BRTO procedure was successfully completed in 93.5% of patients. One patient was allergic to the lauromacrogol injection. A mild postoperative fever occurred in three patients. One patient experienced grand mal seizures after the procedure. There was no significant difference in the median Child-Turcotte-Pugh scores before versus after BRTO. Complete GV resolution was observed in 93.1% of patients. One patient underwent endoscopic treatment for the development of high-risk esophageal varices. Another patient underwent transjugular intrahepatic portosystemic shunt placement for the aggravation of ascites.</p></div><div><h3>Conclusions</h3><p>Lauromacrogol sclerosant foam is safe and effective in patients undergoing BRTO for GV.</p></div>\",\"PeriodicalId\":33533,\"journal\":{\"name\":\"Journal of Interventional Medicine\",\"volume\":\"5 3\",\"pages\":\"Pages 138-142\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cf/76/main.PMC9617148.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Interventional Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2096360222000369\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Interventional Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2096360222000369","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 1

摘要

目的评价聚桂醇硬化剂泡沫球囊闭塞逆行经静脉闭塞术(BRTO)治疗胃静脉曲张合并胃肾静脉分流术的安全性和有效性。方法回顾性分析2016-2020年使用聚桂醇硬化剂泡沫进行BRTO治疗的GV患者的手术成功率、并发症及随访疗效。结果31例患者接受BRTO治疗。将碘化油、聚月桂醇和空气按1:2:3的比例混合制备硬化剂泡沫。93.5%的患者成功完成了BRTO手术。一名患者对聚月桂醇注射液过敏。3例患者术后出现轻度发热。一名患者在手术后出现了严重癫痫发作。BRTO前后child - turcote - pugh评分中位数无显著差异。93.1%的患者GV完全消退。一名患者因发生高危食管静脉曲张而接受内镜治疗。另一名患者因腹水加重而行经颈静脉肝内门静脉分流术。结论聚硫醇硬化剂泡沫治疗GV行BRTO手术安全有效。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

摘要图片

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Balloon-occluded retrograde transvenous obliteration with lauromacrogol sclerosant foam for gastric varices

Objectives

To evaluate the safety and efficacy of balloon-occluded retrograde transvenous obliteration (BRTO) using lauromacrogol sclerosant foam for gastric varices (GVs) with gastrorenal venous shunts.

Methods

Data of GV patients treated with BRTO using lauromacrogol sclerosant foam in 2016–2020 were retrospectively analyzed along with procedural success rate, complications, and follow-up efficacy.

Results

A total of 31 patients were treated with BRTO. The sclerosant foam was prepared by mixing iodinated oil, lauromacrogol, and air at a 1:2:3 ratio. The BRTO procedure was successfully completed in 93.5% of patients. One patient was allergic to the lauromacrogol injection. A mild postoperative fever occurred in three patients. One patient experienced grand mal seizures after the procedure. There was no significant difference in the median Child-Turcotte-Pugh scores before versus after BRTO. Complete GV resolution was observed in 93.1% of patients. One patient underwent endoscopic treatment for the development of high-risk esophageal varices. Another patient underwent transjugular intrahepatic portosystemic shunt placement for the aggravation of ascites.